Skip to content
Indigenous, Medical Health Aged Care

Diabetes inquiry to visit the Northern Territory

Department of the House of Representatives 2 mins read

The Standing Committee on Health, Aged Care and Sport will hold three public hearings this week across Alice Springs and Darwin as part of its inquiry into diabetes.

The Chair of the Committee, Dr Mike Freelander MP, said: ‘As part of this broad inquiry, we are looking at all forms of diabetes including type 1, type 2, gestational diabetes, and other rarer forms such as cystic fibrosis-related diabetes. This week the Committee will hear from a range of stakeholders including:

  • Aboriginal health services and peak bodies
  • Doctors and other health professionals from Alice Springs Hospital and Royal Darwin Hospital
  • The Menzies School of Health Research.

‘The Committee looks forward to speaking with these stakeholders to better understand diabetes prevention, diagnosis and management in regional and remote locations.’

The Deputy Chair of the Committee, Mrs Melissa McIntosh MP, said: ‘The Committee will also hear from individuals with lived experience of diabetes. We anticipate that this will offer a better understanding of the daily realities of living with diabetes in the Northern Territory, including interactions with the healthcare system.’

The Committee intends to hold further public hearings throughout March 2024. Details and dates for further public hearings will be available on the Committee’s website as they are announced.

Public hearing

Date: Wednesday, 6 March 2024
Time: 8.45am – 4.45pm ACST (Alice Springs time)
Location: Ballroom C, DoubleTree by Hilton, 82 Barrett Drive, Alice Springs

Date: Thursday, 7 March 2024
Time: 8.45am – 5.30pm ACST (Darwin time)
Location: Dining Room, Parliament House, 15 Mitchell Street, Darwin City

Date: Friday, 8 March 2024
Time: 8.30am – 10.30am ACST (Darwin time)
Location: Dining Room, Parliament House, 15 Mitchell Street, Darwin City

Programs for the public hearings are available on the inquiry website. A live audio stream of the hearings will also be available on the APH website.

Media inquiries

Dr Mike Freelander MP – Committee Chair
Mike.Freelander.MP@aph.gov.au
(02) 4620 0293

Mrs Melissa McIntosh MP – Committee Deputy Chair
Melissa.McIntosh.MP@aph.gov.au
(02) 4722 0600

For background information

Committee Secretariat
02 6277 4145
Health.Reps@aph.gov.au

More from this category

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

  • Medical Health Aged Care, Science
  • 13/09/2024
  • 11:08
La Trobe University

Centre to play key role in global AI medical research

Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins" before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at La Trobe University's new Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI), launched today, will also apply AI techniques to mRNA therapy development to enable faster design of more precise and effective treatments. Vice-Chancellor Professor Theo Farrell said ACAMI would sit within La Trobe’s…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.